ITMCTR2026001738Active, not recruitingUnknown
Study on Formulation and Clinical Verification of Standardized Protocol for Transcutaneous Electrical Acupoint Stimulation in Promoting Postoperative Gastrointestinal Function Recovery After Peritoneal Cancer Surgery
Beijing Shijitan Hospital, Capital Medical University0 sitesStarted: July 31, 2026Last updated:
Conditions
Trial Snapshot
- Phase
- Unknown
- Status
- Active, not recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 to 75 (—)
- Sex
- All
Inclusion Criteria
- •(1) Patients with primary peritoneal carcinoma or peritoneal metastasis confirmed by imaging combined with pathological or cytological examination, who are planned to receive CRS+HIPEC;
- •(2) Age ranging from 18 to 75 years old;
- •(3) Body mass index (BMI): 18–31 kg/m²;
- •(4) American Society of Anesthesiologists (ASA) physical status classification Grade I–III;
- •(5) Voluntarily participate after full informed consent and sign the written informed consent form.
Exclusion Criteria
- •(1) Scarring, skin infection or sensory disturbance on the skin surrounding target acupoints (Zusanli, Shangjuxu, Hegu, Neiguan);
- •(2) Pre-existing peripheral nerve injury or prior spinal surgery history;
- •(3) Implanted electronic devices such as cardiac pacemakers;
- •(4) Preoperative intestinal obstruction or severe gastrointestinal motility disorders;
- •(5) Long-term preoperative use of analgesic medications;
- •(6) Confirmed psychiatric or neurological disorders;
- •(7) Requirement for intraoperative colostomy;
- •(8) Cognitive dysfunction precluding cooperation with treatment and outcome assessments.
Investigators
Similar Trials
Recruiting
Not Applicable
A clinical study to confirm the efficacy and safety of hard contact lenses for vision correction (SS-200)Corneal astigmatismjRCT203226029030
Recruiting
Phase 1
A trial to investigate the safety and pharmacokinetics of GRT6019 in healthy male participants.2025-523587-20-00Gruenenthal GmbH24
Recruiting
Phase 1
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants with Advanced Solid Malignancies2024-511453-22-00Kumquat Biosciences Inc.112
Recruiting
Phase 1
A study to determine the safety and effect of antibodies against hepatitis D (the SAMBA-D study)2025-522125-36-00Region Midtjylland15
Completed
Phase 1
A Study to Learn About the Study Medicine Called Nirmatrelvir/Ritonavir in People Who are Healthy Volunteers Co-administered the Medicine Rosuvastatin2023-503570-20-00Pfizer Inc.12